ArticleBioorganic & medicinal chemistry letters2015

Synthesis, binding affinity, radiolabeling, and microPET evaluation of 4-(2-substituted-4-substituted)-8-(dialkylamino)-6-methyl-1-substituted-3,4-dihydropyrido[2,3-b]pyrazin-2(1H)-ones as ligands for brain corticotropin-releasing factor type-1 (CRF1) receptors.

Jeffrey S Stehouwer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.